Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley I Bush

Showing results (11-20 of 430) with videos related to

Pageof 43
Sort By:
The Lancet. Neurology|June 17, 2019
Decreasing iron neurotoxicity in pantothenate kinase-associated neurodegenerationScott Ayton, Ashley I Bush
Archives of Neurology|May 19, 2004
Serum copper: a biomarker for Alzheimer disease?Ashley I Bush, Dorothea Strozyk
Chemmedchem|November 15, 2007
Sensitive, selective, and irreversible inhibition of cyclooxygenase-2 activity by copperSeiichi Nagano, Ashley I Bush
Ageing Research Reviews|November 14, 2020
β-amyloid: The known unknownsScott Ayton, Ashley I Bush
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 28, 2020
Iron and Ferroptosis as Therapeutic Targets in Alzheimer's DiseaseAndrew Gleason, Ashley I Bush
European Biophysics Journal : EBJ|November 13, 2007
Twenty years of metallo-neurobiology: where to now?Ashley I Bush, Cyril C Curtain
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
The galvanization of beta-amyloid in Alzheimer's diseaseAshley I Bush, Rudolph E Tanzi
Current Opinion in Chemical Biology|March 18, 2008
Metals in Alzheimer's and Parkinson's diseasesKevin J Barnham, Ashley I Bush
Journal of Neurochemistry|November 8, 2015
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeuticsAbdel A Belaidi, Ashley I Bush
Progress in Neurobiology|May 7, 2010
Biological metals and Alzheimer's disease: implications for therapeutics and diagnosticsJames A Duce, Ashley I Bush
Pageof 43

Showing results (11-20 of 430) with videos related to

Sort By:
Pageof 43
The Lancet. Neurology|June 17, 2019
Decreasing iron neurotoxicity in pantothenate kinase-associated neurodegenerationScott Ayton, Ashley I Bush
Archives of Neurology|May 19, 2004
Serum copper: a biomarker for Alzheimer disease?Ashley I Bush, Dorothea Strozyk
Chemmedchem|November 15, 2007
Sensitive, selective, and irreversible inhibition of cyclooxygenase-2 activity by copperSeiichi Nagano, Ashley I Bush
Ageing Research Reviews|November 14, 2020
β-amyloid: The known unknownsScott Ayton, Ashley I Bush
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 28, 2020
Iron and Ferroptosis as Therapeutic Targets in Alzheimer's DiseaseAndrew Gleason, Ashley I Bush
European Biophysics Journal : EBJ|November 13, 2007
Twenty years of metallo-neurobiology: where to now?Ashley I Bush, Cyril C Curtain
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
The galvanization of beta-amyloid in Alzheimer's diseaseAshley I Bush, Rudolph E Tanzi
Current Opinion in Chemical Biology|March 18, 2008
Metals in Alzheimer's and Parkinson's diseasesKevin J Barnham, Ashley I Bush
Journal of Neurochemistry|November 8, 2015
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeuticsAbdel A Belaidi, Ashley I Bush
Progress in Neurobiology|May 7, 2010
Biological metals and Alzheimer's disease: implications for therapeutics and diagnosticsJames A Duce, Ashley I Bush
Pageof 43